Single-dose azithromycin was as effective as three-day erythromycin for the treatment of children with cholera, according to the results of a double-blind randomized trial reported in the Nov. 30 issue of The Lancet.
“Whether or not the potential advantages of single-dose azithromycin increased compliance, simplified logistics, reduction in vomiting justify the additional cost when compared with other drug regimens is a decision that individual treatment centers involved in the care of children with cholera will have to make,” lead author Wasif A. Khan, from the ICDDRB, Centre for Health and Population Research in Bangladesh, says in a news release.
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!